Skip to Content
You are currently on the new version of our website. Access the old version .
CancersCancers
  • Editorial
  • Open Access

28 October 2024

3 Pages

State of the Art and New Perspectives in Lung Cancer Therapeutics

,
,
and
1
First University Department of Respiratory Medicine, ‘Sotiria’ Chest Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
2
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
*
Author to whom correspondence should be addressed.
This article belongs to the Section Tumor Microenvironment

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Cisplatin became a first-line chemotherapy regimen for lung cancer in the mid-1980s, marking a pivotal advance in lung cancer treatment [...]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.